| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |